Cargando…

Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Rosell, Rafael, González-Cao, María, Codony-Servat, Jordi, Molina-Vila, Miguel Angel, de las Casas, Clara Mayo, Ito, Masaoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080327/
https://www.ncbi.nlm.nih.gov/pubmed/37033354
http://dx.doi.org/10.21037/tcr-22-2888
_version_ 1785020898368028672
author Rosell, Rafael
González-Cao, María
Codony-Servat, Jordi
Molina-Vila, Miguel Angel
de las Casas, Clara Mayo
Ito, Masaoki
author_facet Rosell, Rafael
González-Cao, María
Codony-Servat, Jordi
Molina-Vila, Miguel Angel
de las Casas, Clara Mayo
Ito, Masaoki
author_sort Rosell, Rafael
collection PubMed
description
format Online
Article
Text
id pubmed-10080327
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-100803272023-04-08 Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer Rosell, Rafael González-Cao, María Codony-Servat, Jordi Molina-Vila, Miguel Angel de las Casas, Clara Mayo Ito, Masaoki Transl Cancer Res Editorial AME Publishing Company 2023-03-14 2023-03-31 /pmc/articles/PMC10080327/ /pubmed/37033354 http://dx.doi.org/10.21037/tcr-22-2888 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial
Rosell, Rafael
González-Cao, María
Codony-Servat, Jordi
Molina-Vila, Miguel Angel
de las Casas, Clara Mayo
Ito, Masaoki
Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
title Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
title_full Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
title_fullStr Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
title_full_unstemmed Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
title_short Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
title_sort acquired braf gene fusions in osimertinib resistant egfr-mutant non-small cell lung cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080327/
https://www.ncbi.nlm.nih.gov/pubmed/37033354
http://dx.doi.org/10.21037/tcr-22-2888
work_keys_str_mv AT rosellrafael acquiredbrafgenefusionsinosimertinibresistantegfrmutantnonsmallcelllungcancer
AT gonzalezcaomaria acquiredbrafgenefusionsinosimertinibresistantegfrmutantnonsmallcelllungcancer
AT codonyservatjordi acquiredbrafgenefusionsinosimertinibresistantegfrmutantnonsmallcelllungcancer
AT molinavilamiguelangel acquiredbrafgenefusionsinosimertinibresistantegfrmutantnonsmallcelllungcancer
AT delascasasclaramayo acquiredbrafgenefusionsinosimertinibresistantegfrmutantnonsmallcelllungcancer
AT itomasaoki acquiredbrafgenefusionsinosimertinibresistantegfrmutantnonsmallcelllungcancer